Jinkaiseng Biology: Qilu Investment and Qingsong Investment plan to reduce their shareholdings by 3% and 1% respectively.

Jinkai Life Sciences announced that shareholder Qilu Investment Plan will reduce its holdings by no more than 3.612 million shares, accounting for 3% of the total share capital of the company. Among them, the reduction through centralized bidding will not exceed 1.204 million shares, accounting for 1% of the total share capital of the company; the reduction through block trading will not exceed 2.408 million shares, accounting for 2% of the total share capital of the company. Shareholder Qingsong Investment Plan will reduce its holdings by no more than 1.204 million shares through centralized bidding, accounting for 1% of the total share capital of the company. The reduction period is within three months after fifteen trading days from the date of the announcement.